Trial Profile
Identifing medical predictors of anti-hypertensive effect of eplerenone.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2017
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms IMPRESSIVE
- 15 Sep 2017 Status changed from recruiting to completed.
- 04 Feb 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Feb 2010 Actual initiation date (Sep 2009) added as reported by University Hospital Medical Information Network - Japan.